Market Cap

Merus N.V. Market Capitalization:

$4.01 Billion

USD as of July 1, 2025

business Merus N.V. Company Profile

Merus N.V. Main Stock Listing

NASDAQ: MRUS

Market Capitalization History of Merus N.V.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $309.91 B
Vertex Pharmaceuticals Incorporated $117.36 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $59.14 B
Marinomed Biotech AG $58.56 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Merus N.V. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $2.83 B 71.73%
Jan. 1, 2024 $1.65 B 130.46%
Jan. 1, 2023 $714.5 M -37.30%
Jan. 1, 2022 $1.14 B -10.57%
Jan. 1, 2021 $1.27 B 68.32%
Jan. 1, 2020 $757.1 M 35.01%
Jan. 1, 2019 $560.7 M -34.82%
Jan. 1, 2018 $860.3 M -28.84%
Jan. 1, 2017 $1.21 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Merus N.V. Categories

Netherlands languages Healthcare languages Biotechnology
Netherlands Healthcare Netherlands Biotechnology

Stocks & Indices

Merus N.V. has the following listings and related stock indices.


Stock: NASDAQ: MRUS

Stock: FSX: 2GH

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.